Catheter Precision, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
AMEX
SCHEDULE 13D/A: Catheter Precision CEO David Jenkins Receives Significant Stock Option Grant, Updates Beneficial Ownership
Catheter Precision, Inc. has filed an amended Schedule 13D revealing an updated beneficial ownership stake for CEO David Jenkins and related entities, alongside a new grant of 450,000 stock options to Mr. Jenkins.
AMEX
SCHEDULE 13D/A: Major Shareholder Increases Stake in Catheter Precision, Details Warrant Transactions
Casey A. Jenkins and the Jenkins Family Charitable Institute have updated their beneficial ownership in Catheter Precision, Inc., increasing their aggregate stake to 9.9% and detailing recent warrant transactions and transfers.